Background The main causes of mortality in patients with chronic heart failure include
sudden cardiac death (SCD) and progressive heart failure. Autonomic dysfunction plays a …

Despite significant advances in heart failure diagnostics and therapy, the prognosis remains
poor, with one in three dying within a year of hospital admission. This is at least in part due …

The implantable cardioverter-defibrillator (ICD) is effective to prevent sudden cardiac death
(SCD) in selected patients with heart disease known to be at high risk for ventricular …

Introduction: Risk stratification for sudden cardiac death in non-ischemic dilated
cardiomyopathy (NIDCM) remains a clinical challenge. Areas covered: Currently, left …

Over the last decades, tremendous successes have been achieved in the management of
sudden cardiac death in patients with heart failure by use of the implantable cardioverter …

Abstract Background Implantable cardioverter-defibrillators (ICDs) are widely used for the
prevention of sudden cardiac death. At present, both clinical benefit and cost-effectiveness …

Abstract Background Cardiac troponin T (cTnT) has been reported to be associated with
cardiac mortality. In the present study, we evaluated the role of routine assessment of cTnT …

Cardiac resynchronization therapy (CRT) in patients with heart failure (HF) with reduced
ejection fraction (HFREF) with prolonged QRS intervals has resulted in marked durable …

Temporal Trends Over a Decade of Defibrillator Therapy Background Technology and
clinical practice surrounding the use of the primary prevention implantable cardioverter …

Ventricular arrhythmias are an important cause of cardiovascular morbidity and mortality,
particularly in those with structural heart disease, inherited cardiomyopathies, and …